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ABSTRACT 
Background: Early identification of high-risk individuals is essential in the prevention 
and control of type 2 Diabetes Mellitus (T2DM). This study assessed the risk of T2DM 
and validated the American Diabetes Association (ADA) risk tool among urban Nigerian 
women. 
Methods:  This was a cross-sectional study of 159 consenting women aged ≥18 years, 
consecutively recruited at a medical outreach in Sapele, Delta State, Nigeria. The risk of 
T2DM was assessed with a modified ADA risk tool. Respondents’ weight, height, blood 
pressure and blood glucose levels were measured. Data were analyzed using SPSS version 
23.0.   
Results:  The participants had a mean age of: 41.5(±13.2) years, body mass index:  
27.3(±5.38) kg/m2, SBP: 128(±19.4) mmHg and DBP: 81(±10.8) mmHg. Five (3.1%) 
reported a history of gestational diabetes, 21 (13.2%) had a first degree relative with 
T2DM, 26 (16.4%) were physically inactive, and 37 (23.3%) reported a history of 
hypertension/use of anti-hypertensives. Forty-eight (30.2%) had a high-risk for 
prediabetes and undiagnosed DM. The ADA risk tool was found to be useful with 
sensitivity (81.8%), specificity (73.6%), and ROC area under the curve (0.848, 95%CI: 
0.743–0.953). Respondents with a high-risk of prediabetes and undiagnosed DM had 
significantly higher mean BMI (30.7 vs 25.9kg/m2), SBP (141.9 vs 122.5mmHg) and DBP 
(85.9 vs 79.1 mmHg).  
Conclusion: The performance of the ADA Risk Tool was useful in this study. One-in-
three respondents had a high-risk of prediabetes and undiagnosed DM. 
Overweight/obesity, older age, gestational diabetes and hypertension were significantly 
associated with a high-risk for prediabetes and undiagnosed DM among women. 
Correspondence to: 
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Type 2 diabetes mellitus (DM) is a non-
communicable disease with growing global 
public health significance. The burden of 
DM is highest in low- and middle-income 
countries. Indeed, about 80% of the 425 
million persons with DM live in these 
developing economies.1 The prevalence of 
DM in Nigeria is increasing.2 In a systematic 
review and meta-analysis of the 
epidemiological burden of DM in Nigeria, 
Uloko et al  estimated the overall pooled 
prevalence of DM from 23 studies spanning 
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between 1999 and 2016 as 5.77%.3 
Compared to the reported national 
prevalence of 2.2% in 1992, the pooled 
prevalence was a 2.6-fold increase.4  Uloko 
et al also noted variations in the pooled 
prevalence of DM across the six geopolitical 
zones in Nigeria; highest in South-South 
(9.8%) and lowest in North-West (3.0%).3 
Complications of DM contribute towards a 
substantial proportion of non-
communicable related-deaths, morbidities 
and disabilities. In 2017, an estimated 4 
million deaths were attributed to DM, chiefly 
from stroke, heart and kidney diseases.1 
Indeed, DM is a cardiovascular disease risk 
equivalent.  
Globally, approximately 50% of persons 
living with DM are undiagnosed. The 
proportion of undiagnosed DM, however, 
has regional differences; being highest in 
Africa (69.2%).1 In the same vein, many are 
unaware of their risk of DM and as such, do 
not take proactive measures to prevent the 
disease.1 Type 2 DM is associated with 
urbanization and lifestyle choices that 
promote the consumption of unhealthy diet, 
overweight/obesity, and physical 
inactivity.1 In low- and middle-income 
countries like Nigeria and India, urban 
populations are at an increased risk of 
developing DM. 3, 5 Although, there is no 
gender predilection in the development of 
type 2 DM, the adverse consequences of the 
disease are severely more in women than 
men. For example, women with DM are 50% 
more likely to die prematurely from 
cardiovascular disease than their male 
counterparts. 6-8 This may be partly 
explained by the fact that women with 
myocardial infarction complicating DM 
present with atypical symptoms and are less 
likely to receive prompt treatment as 
outlined in evidenced-based guidelines 
compared to their male counterparts.8, 9 
Gender inequity and lack of empowerment 
in women also influence their health-
seeking behaviours and access to 
healthcare.10 Indeed, more women than 
men die from DM. Of the nearly 4 million 
DM related deaths in 2017, there were 0.3 
million more deaths in women than men.1 
The definitive diagnosis of DM is made 
usually by biochemical tests of blood 
samples for blood glucose and glycated 
haemoglobin (HbA1C). However, there are 
several useful non-invasive risk-prediction 
tools for screening for prediabetes and 
undiagnosed diabetes in community 
surveys and clinical practice.11-16 Ethnic 
differences affect the usefulness and 
practicability of a risk-prediction tool. For 
example, compared to the American 
Diabetes (ADA) risk tool, and the National 
Health and Nutrition Examination Survey 
Risk Score, the Finnish Diabetes Risk Score 
(FINDRISC) tool is most useful when 
screening Caucasian population.12 
Although the ADA risk assessment tool was 
developed for use in Caucasian and black 
populations, it has also been validated for 
use among other ethnic groups in Asia.15, 16 
This gives credence to its usefulness across 
a range of diverse populations. The ADA risk 
tool has also been found to have better 
accuracy compared to other diabetes risk 
assessment tools including the Rotterdam 
49 
 
JOURNAL OF COMMUNITY MEDICINE AND PRIMARY HEALTH CARE VOL. 32, NO 1, MARCH 2020 
model and the FINDRISC tool when used to 
screen women for prediabetes, and 
undiagnosed DM.15 Like most other risk 
prediction tools, the ADA risk assessment 
tool is simple, easy and quick to 
administer.13 
This study, therefore, aimed primarily at 
assessing the risk of prediabetes and 
undiagnosed DM among women in an urban 
community in Delta State, South-South, 
Nigeria, using the American Diabetes (ADA) 
risk tool. The accuracy of the ADA risk tool 
will also be assessed as this tool has not 
been previously validated for use among 
Nigerians. 
METHODOLOGY 
The cross-sectional study was conducted in 
Sapele, Delta State, South-South, Nigeria. 
Sapele is one of the urban communities in 
the oil-rich Delta State. The estimated 
population of Sapele is over 161,000 
persons. The study population was selected 
from a cluster of women who attended a free 
medical outreach programme in Sapele. The 
programme, which held in May 2019, was 
put together by the women’s group of a 
faith-based organization and targeted 
women primarily.  
Women aged at least 18 years were 
consecutively recruited for the study. 
Women with a known history of diabetes 
mellitus and non-consenting women were 
excluded from the study. The Cochrane 
formula was employed to determine the 
minimum sample size for this study.17 
Applying the prevalence rate of type 2 
diabetes mellitus of 9.8% in South-South 
Nigeria,3 and assuming a 95% confidence 
interval, an alpha (type 1) error margin of 
5%, and a non-response rate of 10%, the 
minimum sample size for this study is 137.  
Ethical approval was obtained from the 
Delta State University Teaching Hospital 
(DELSUTH) Health Research Ethics 
Committee (HREC). Refusal to participate in 
the study did not in any way interfere with 
the activities of the medical outreach, which 
included health talk on diabetes mellitus 
and other non-communicable diseases, and 
screening for cervical cancer.  
The study questionnaire was a modified 
American Diabetes Association (ADA) Risk 
Tool.13 The ADA risk assessment tool is a 
simple 7-item questionnaire for assessing 
the risk of prediabetes and undiagnosed 
DM. Unlike the ADA risk assessment tool, 
the study questionnaire had questions in six 
domains. Sex, which is scored one (1) for 
males and zero (0) for females in the ADA 
risk tool, was not included in the study 
questionnaire. All the respondents in this 
study were females and would have been 
scored zero. The six domains tested in this 
study were age, history of gestational 
diabetes (GDM), family history of DM, high 
blood pressure, body weight status, and 
physical activity. Each question had points 
apportioned to the provided response. Age 
group was scored 0, 1, 2, and 3 points for 
<40, 40-49, 50-59, ≥60 years, respectively. 
A positive history of GDM, family history of 
DM, high blood pressure, or use of 
antihypertensive medications, physically 
inactivity attracted one (1) point each. 
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Respondents who had never been pregnant 
or had no known history of GDM were 
scored zero (0).  Respondents who had no 
known family history of DM and those who 
were not hypertensive were scored zero (0).  
The physical activity level of the 
respondents was assessed by asking if they 
engaged in any form of physical exercise (as 
part of their work, means of transportation, 
or for recreation) that makes their heartbeat 
and breathing faster continuously for at 
least 10 minutes. Respondents who did not 
engage in these physical activities regularly 
(at least three days in a typical week) were 
tagged physically inactive and scored one (1) 
point. The weight status of each respondent 
was determined from a chart on the ADA 
risk tool using their weight and height and 
attracted scores ranging from 0 – 3 points. 
Points scored by each respondent were 
summed up. The total minimum and 
maximum scores obtainable are zero (0) and 
ten (10), respectively. A maximum total 
score of 0-3 implies a low risk of prediabetes 
or type 2 DM, while maximum scores of ≥5 
suggest a high risk of type 2 DM. However, 
respondents with total scores of 4 and above 
were likely to have prediabetes or a high risk 
of undiagnosed type 2 DM. Thus, a score of 
5 and above precludes prediabetes. 
Although the ADA Risk Tool was originally 
intended to be self-administered, the 
modified version (study questionnaire) was 
administered to the respondents by the 
interviewer. After that, all the respondents 
had physical measurements performed. 
Anthropometric measurements obtained 
were weight and height.  Before measuring 
the weight and height, each respondent was 
asked to remove footwear, headgears/caps, 
any heavy clothing and empty their pockets. 
While standing erect on the middle of the 
weighing scale, weights were recorded to the 
nearest 0.1kg. While still barefooted and 
with no headgear/caps on, the hair (if any) 
was pressed down, and the height measured 
using a metre rule to the nearest 0.1cm.  
Using the ADA risk tool, the weight status of 
the respondent was noted and appropriately 
scored. Also, the body mass index was 
calculated for all respondents and 
categorized using the World Health 
Organization (WHO) classification as 
underweight (<18.5kg/m2), normal weight 
(18.5 – 24.9 kg/m2), overweight (25.0 – 29.9 
kg/m2), and obese (≥30.0 kg/m2).11  
The blood pressure of respondents was 
measured thrice at an interval of 1 minute 
using the Omron® sphygmomanometer in 
the seated position after initial rest of at 
least 5 minutes. The average blood pressure 
reading was computed and categorized 
according to the Joint National Committee 7 
classification15 as follows: normal (SBP 
<120mmHg and DBP <80mmH),  
prehypertension (SBP 120-139mmHg, or 
DBP 80-89mmHg), stage 1 hypertension 
(SBP 140-159mmHg, or DBP 90-99mmHg), 
and stage 2 hypertension (SBP ≥160mmHg, 
or DBP ≥100mmHg). Respondents who were 
on anti-hypertensive medications were 
scored 1 point irrespective of their blood 
pressure reading. Finally, all the 
respondents had point-of-care testing for 
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blood glucose using a capillary blood 
sample. Blood glucose level was categorized 
using the American Diabetes Association 
classification: 16 Random blood glucose 
(mg/dl) levels <140, 140-199 and ≥200 were 
classified as normal, prediabetes and 
diabetes, respectively. Fasting blood glucose 
(mg/dl) levels <110, 110-125 and ≥126 were 
classified as normal, prediabetes and 
diabetes, respectively.  
Obtained data were inputted to a 
spreadsheet. The analysis was done using 
the International Business Machine (IBM) 
Statistical Package for Scientific Solutions 
(SPSS) version 22 (IBM SPSS Corp., Armonk 
NY, USA). Summaries of categorical 
variables were presented as frequencies and 
percentages in tables and charts. 
Associations between categorical variables 
such as history of gestational diabetes and 
the risk of prediabetes/undiagnosed DM 
were tested using the Chi-square test. 
Summaries of continuous variables such as 
age, body mass index and blood pressure 
were expressed as means and standard 
deviation of means.  
Differences in mean were tested using the 
independent T-test. Bivariate correlation of 
factors associated with diabetes risk was 
done using Pearson's correlation coefficient. 
Binary logistic regression analysis was used 
to explore the relationship between the risk 
of prediabetes and undiagnosed DM and the 
predictors of risk factors associated with the 
development of type 2 DM. Statistical 
significance noted at a p-value level of less 
than 5%. 
RESULTS 
One hundred and fifty-nine women were 
recruited for the study. Their mean age was 
41.5 (±13.2) years. (Table 1) Five (3.1%) of 
the women reported a history of gestational 
diabetes, while 21 (13.2%) had a first degree 
relative (parents or siblings) with DM. A 
positive personal history of hypertension or 
use of antihypertensive medications was 
obtained from 37 (23.3%) of the 
respondents. Twenty-six (16.4%) of the 
respondents reported that they were 
physically inactive.  
Table 1 shows the biophysical 
characteristics of the respondents. One 
hundred and twenty-seven (79.9%) of the 
respondents’ blood glucose levels were 
within the normal range, with an overall 
mean blood glucose level of 102 (±36.4) 
mg/dl. The mean BMI of the respondents 
was 27.3 (±5.38) kg/m2. One hundred and 
five (66.0%) of the respondents were 
overweight and obese. The mean SBP and 
DBP were 128 (±19.4) mmHg and 81 (±10.8) 
mmHg, respectively.   
The ADA risk score for the respondents 
ranged between 0 and 6, with a mean score 
of 2.51 (±1.66). The frequency distribution 
of the diabetes risk score is shown in figure 
1. The risk of prediabetes and undiagnosed 
DM was low (ADA risk score 0-3) in 111 
(69.8%) respondents and high (ADA risk 
score ≥4) in 48 (30.2%). Among the 
respondents with a high risk of prediabetes 
and undiagnosed DM, 22 (45.8%) had an 
ADA risk score of ≥5. Thus, 26 (16.4%) of all 
the respondents were at risk of prediabetes.  
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Table 1: Biophysical characteristics of the 
study population 
Variable Category Frequency (%) 
 
Age group  
(years) 
<40 69 (43.4) 
40-49 49 (30.8) 
50-59 24 (15.1) 
≥60 17 (10.7) 
Mean (±SD) 41.5 (±13.2) 
 
Blood Glucose*  
(mg/dl) 
Normal 127 (79.9) 
Prediabetic 19 (11.9) 
Diabetic 13 (8.2) 





Underweight 4 (2.5) 
Normal 50 (31.4) 
Overweight 57 (35.8) 
Obese 48 (30.2) 
Mean (±SD) 27.3 (±5.38) 
 
Blood Pressure  
(mmHg) 
Normal 44 (27.7) 
Pre-HTN 63 (39.6) 
Stage 1 HTN 37 (23.3) 
Stage 2 HTN 15 (9.4) 
Mean SBP (±SD) 128 (±19.4) 
Mean DBP (±SD) 81 (±10.8) 
n=159, *Random / Fasting blood glucose, DBP: Diastolic 
Blood Pressure, SBP: Systolic Blood Pressure,  
SD: Standard Deviation 
 
Compared to diagnostic testing for 
prediabetes and diabetes using blood 
glucose levels, the ADA risk tool had 
specificity and sensitivity of 73.6% and 
81.8%, respectively. Using the receiver 
operating characteristics (ROC), the area 
under curve (AUC) was 0.848 (95% CI: 
0.743 – 0.953). (Figure 2) 
Table 2 shows the association between the 
risk for prediabetes and undiagnosed DM 
and biophysical/other profile of 
respondents. The proportion of respondents 
with high risk for prediabetes and 
undiagnosed DM increased with age from 2 
(2.9%) among those aged <40 years to 14 
(82.4%) among those aged ≥60 years. The 
association between age and risk for 
prediabetes and undiagnosed DM was 
statistically significant (ꭓ2=65.149, 
p<0.001). All the respondents who reported 
a history of GDM were high risk. The 
association between GDM and the risk 
category for prediabetes and undiagnosed 
DM was statistically significant (ꭓ2=11.938, 
p=0.001). About 60% of the respondents 
who were obese had high risk.  
The association between BMI category and 
risk for prediabetes and undiagnosed DM 
was statistically significant (ꭓ2=32.005, 
p<0.001). The proportion of respondents 
with high risk for prediabetes and 
undiagnosed DM increased with increasing 
blood pressure (BP) readings from 5 (10.4%) 
among those whose BP were <120/80mmHg 
(normal) to 10 (66.7%) among those whose 
BP readings were ≥160/100mmHg (stage 2 
hypertension). The association between BP 
readings and risk for prediabetes and 
undiagnosed DM was statistically 
significant (χ2=21.915, p<0.001). Family 
history of DM and physical inactivity did not 
significantly differ among respondents with 
high and low risk for prediabetes and 
undiagnosed DM. (Table 2) 
Binary logistics regression showed that 
increasing age, being overweight and obese, 
and a positive history of hypertension were 
significant independent predictors of the 
risk for prediabetes and undiagnosed type 2 
DM. (Table 3)  
The mean BMI, SBP, DBP, pulse pressure, 
and blood glucose of respondents with a 
high risk of prediabetes and undiagnosed  
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Figure 1: Diabetes risk score of the respondents using the ADA risk assessment tool 
 
diabetes (ADA risk score ≥4) were 
significantly higher than those with low risk. 
(Table 4) The correlation between diabetes 
risk score and blood glucose, blood pressure 
(systolic and diastolic), body mass index was 
statistically significant, as shown in table 5. 
 
DISCUSSION 
The need for early identification of high-risk 
individuals is of the utmost importance in 
the drive to effectively prevent and reduce 
the disease burden associated with DM.  
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Table 2: Association between respondents’ biophysical/other profile and risk of prediabetes and 
undiagnosed DM   







Age group  
(years) 
<40 2 (2.9) 67 (97.1) <0.001 
40-49 15 (30.6) 34 (69.4) 
50-59 17 (70.8) 7 (29.2) 
≥60 14 (82.4) 3 (17.6) 
 
Family History of DM Yes 10 (47.6) 11 (52.4) 0.062 
No 38 (27.5) 100 (72.5) 
 
History of Gestational DM Yes 5 (100.0) 0 (0.0) 0.001 
No 43 (27.7) 111 (72.1) 
 
History of hypertension/use of anti-
hypertensives 
 
Yes 26 (70.3) 11 (29.7) <0.001 
No 22 (18.0) 100 (82.0) 
Physical Inactivity Yes 12 (46.2) 14 (53.8) 0.053 
 No 36 (27.1) 97 (72.9) 
 
BMI Underweight 1 (25.0) 3 (75.0) <0.001 
Normal 5 (10.0) 45 (90.0) 
Overweight 13 (22.8) 44 (77.2) 
Obese 29 (60.4) 19 (39.6) 
 
Blood Pressure  Normal 5 (11.4) 39 (88.6) <0.001 
Pre-HTN 16 (25.4) 47 (74.6) 
Stage 1 HTN 17 (45.9) 20 (54.1) 
Stage 2 HTN 10 (66.7) 5 (33.3) 
 
Blood Glucose  Normal 29 (22.8) 98 (77.2) <0.001 
Prediabetic 9 (47.4) 10 (52.6) 
Diabetic 10 (76.9) 3 (23.1) 
BMI: Body Mass Index, DM: Diabetes Mellitus, HTN: Hypertension 
 
 
Table 3: Logistic regression for likely predictors of the risk of prediabetes and undiagnosed DM 
Variable  Category B Standard error Wald Odds ratio p-value 
Age (years) <40 Reference   17.709  0.001 
40-49 2.788 1.310 4.528 16.242 0.033 
50-59 7.787 2.222 12.284 2408.477 <0.001 











Normal  -5.311 12.716 0.174 0.005 0.676 
Overweight  -6.648 1.877 12.546 0.001 <0.001 





























BMI: Body Mass Index, GDM: Gestational Diabetes Mellitus, HTN: Hypertension 
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Table 4. Mean differences in the biophysical profile of respondents with high and low risk for 
prediabetes and undiagnosed DM 
Variables 
 
Mean (±SD) 95% CI 
 
p-value 
Low Risk  High Risk 
Age (years) 40.5 (±12.8) 43.9 (±14.0) -7.92 to 1.07 0.134 
BMI (kg/m2) 25.9 (±4.6) 30.7 (±5.5) -6.50 to -3.14 <0.001 
SBP (mmHg) 122.5 (±15.1) 141.9 (21.7) -25.22 to -13.40 <0.001 
DBP (mmHg) 79.1 (±9.8) 85.9 (±11.6) -10.32 to -3.22 <0.001 
Pulse Pressure (mmHg) 43.4 (±10.9) 556.0 (±15.9) -16.85 to -8.24 <0.001 
Blood glucose (mg/dl) 94.2 (±14.5) 120.8 (±58.7) -38.51 to -14.74 <0.001 
BMI: Body Mass Index, CI: Confidence Interval, DBP: Diastolic Blood Pressure, SBP: Systolic Blood Pressure, 
SD: Standard Deviation,  
 
 
Table 5. Correlation of diabetes risk score and associated factors 
 Pearson’s Correlation Coefficient (R) p-value 
Age 0.710 <0.001 
BMI 0.590 <0.001 
SBP 0.499 <0.001 
DBP 0.341 <0.001 
Pulse Pressure 0.433 <0.001 
Blood Glucose 0.346 <0.001 
BMI: Body Mass Index, DBP: Diastolic Blood Pressure, SBP: Systolic Blood Pressure 
 
The American Diabetes Association (ADA) 
Risk Tool is an easily administered, cheap, 
and non-invasive tool to screen persons with 
high risk for developing type 2 DM.13 
Although there is no previous literature 
validating its use in Nigeria, findings from 
the index study validate its accuracy and 
usefulness. The receiving operating 
characteristics (ROC) area under curve of 
0.848 affirms that the accuracy of ADA Risk 
Tool as a good and useful screening for 
prediabetes and undiagnosed diabetes 
among urban Nigerian women. The ADA 
risk tool has also been validated to be useful 
in other regions of the World.13-16, 21 For 
example, its usefulness has been validated 
in predicting the 3-year incidence of 
prediabetes and diabetes among Taiwanese 
women.15 There is, however, a need for 
further research to validate the usefulness 
of the ADA risk tool among Nigerian men as 
well as in rural populations in Nigeria. 
Using the ADA Risk Tool at a cut-off score of 
4.0, the risk assessment of prediabetes and 
undiagnosed diabetes in this study was high 
(30.2%). This finding supports earlier 
reports that women and urban dwellers are 
at a high risk of developing DM as the study 
population was drawn from among female 
urban dwellers. Previous studies involving 
both genders have also shown that women 
have a higher risk of DM than men.22, 23 
Also, the prevalence of DM in developing 
economies is generally higher in urban than 
rural areas. 3, 5, 24 In the index study, 8.4% 
of the study population had blood glucose 
readings in the diabetic range. This figure, 
although lower, is not much different from 
56 
 
JOURNAL OF COMMUNITY MEDICINE AND PRIMARY HEALTH CARE VOL. 32, NO 1, MARCH 2020 
the pooled prevalence of DM of 9.8% in 
South-South Nigeria.3  
Urbanization has been linked with several 
unhealthy lifestyles that result in obesity, 
and by extension, the development of DM. 
In this study, 66.0% of the women had high 
BMI (≥25.0kg/m2). The women who had 
high-risk of prediabetes and undiagnosed 
DM had significantly higher mean BMI. 
They also had higher mean systolic and 
diastolic blood pressures as well as higher 
blood glucose compared with the low-risk 
women. Indeed, BMI, blood pressure, age, 
and blood glucose levels showed significant 
correlation with the ADA risk scores in this 
study. However, the significant predictors of 
high risk for prediabetes and undiagnosed 
DM were advancing age, high BMI 
(overweight and obese), and a positive 
history of hypertension. Age was, however, 
the strongest predictor identified. 
Considering that over 40% of the women in 
this study were aged less than 40 years, the 
future risk for diabetes in the community is 
likely to increase with time. This is 
particularly worrisome and calls for urgent 
interventions to forestall the looming 
disaster, particularly as women have been 
shown to have worse adverse cardiovascular 
outcomes from complications of DM.6 - 8 
This study is not without its limitations. 
Firstly, sampling was by convenience, non-
probability method, and can limit the 
generalization of inferences made. The 
choice to study only women also limited the 
generalization of the performance of the 
ADA risk tool in men.  Also, recall bias and 
lack of awareness of the correct response to 
some of the questions like the family history 
of DM and history of gestational diabetes 
cannot be entirely excluded. 
This study validates the American Diabetes 
Association (ADA) Risk Tool as a good and 
useful screening tool for prediabetes and 
undiagnosed diabetes among Nigerian 
women in urban settings. Using this tool, 
one-in-three women in the population 
studied had a high risk of prediabetes and 
undiagnosed diabetes. The ADA risk tool is, 
therefore, strongly recommended for routine 
screening of women to identify those at risk 
of type 2 diabetes. It is advocated that the 
use of the ADA risk tool be incorporated into 
antenatal services in Nigeria for a wider 
reach. Further research is needed to 
validate the usefulness of the ADA risk tool 
among Nigerian men. 
Overweight and obesity, older age, history of 
hypertension were significant predictors of 
high-risk for prediabetes and undiagnosed 
DM among women. Promotion of healthy 
lifestyle choices, maintenance of healthy 
weight, and normal blood pressure should 
be in the front burner in the prevention of 
type 2 diabetes.   
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